Efficacy and Safety of Autologous Stromal Vascular Fraction in the Treatment of Empty Nose Syndrome
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. Regenerative treatment using stem cells may serve as treatment option for empty nose syndrome (ENS), which is caused by the lack of turbinate tissue and deranged nervous system in the nasal cavity. We aimed to assess the efficacy and safety of the autologous stromal vascular fraction (SVF) in the treatment of ENS. Methods. In this prospective observational clinical study, we enrolled 10 ENS patients who volunteered to undergo treatment of ENS through the injection of autologous SVF. Data, including demographic data, pre- and postoperative Sino-Nasal Outcome Test-25 (SNOT-25) scores, overall patient satisfaction, and postoperative complications, were prospectively collected. Nasal secretion was assessed using the polyurethane foam absorption method, and the levels of biological markers were analyzed in both ENS group and control group using enzyme-linked immunosorbent assay. The SVF extracted from abdominal fat was diluted and injected into both inferior turbinates. Results. Among the 10 initial patients, one was excluded from the study. Subjective satisfaction was rated as “much improved” in two and “no change” in seven. Among the improved patients, the mean preinjection SNOT-25 score was 55.0 and the score at 6 months after injection was 19.5. However, the average SNOT-25 score of nine participants at 6 months after injection (mean±standard deviation, 62.4±35.8) did not differ significantly from the baseline SNOT-25 score (70.1±24.7, P>0.05, respectively). Among the various inflammatory markers assessed, the levels of interleukin (IL)-1β, IL-8, and calcitonin gene-related peptide were significantly higher in ENS patients. Compared with preinjection secretion level, the nasal secretions from SVF-treated patients showed decreased expressions of IL-1β and IL-8 after injection. Conclusion. Although SVF treatment appears to decrease the inflammatory cytokine levels in the nasal mucosa, a single SVF injection was not effective in terms of symptom improvement and patient satisfaction. Further trials are needed to identify a more practical and useful regenerative treatment modality for patients with ENS.
Abstract
Objectives. Regenerative treatment using stem cells may serve as treatment option for empty nose syndrome (ENS), which is caused by the lack of turbinate tissue and deranged nervous system in the nasal cavity. We aimed to assess the efficacy and safety of the autologous stromal vascular fraction (SVF) in the treatment of ENS. Methods. In this prospective observational clinical study, we enrolled 10 ENS patients who volunteered to undergo treatment of ENS through the injection of autologous SVF. Data, including demographic data, pre- and postoperative Sino-Nasal Outcome Test-25 (SNOT-25) scores, overall patient satisfaction, and postoperative complications, were prospectively collected. Nasal secretion was assessed using the polyurethane foam absorption method, and the levels of biological markers were analyzed in both ENS group and control group using enzyme-linked immunosorbent assay. The SVF extracted from abdominal fat was diluted and injected into both inferior turbinates. Results. Among the 10 initial patients, one was excluded from the study. Subjective satisfaction was rated as “much improved” in two and “no change” in seven. Among the improved patients, the mean preinjection SNOT-25 score was 55.0 and the score at 6 months after injection was 19.5. However, the average SNOT-25 score of nine participants at 6 months after injection (mean±standard deviation, 62.4±35.8) did not differ significantly from the baseline SNOT-25 score (70.1±24.7, P>0.05, respectively). Among the various inflammatory markers assessed, the levels of interleukin (IL)-1β, IL-8, and calcitonin gene-related peptide were significantly higher in ENS patients. Compared with preinjection secretion level, the nasal secretions from SVF-treated patients showed decreased expressions of IL-1β and IL-8 after injection. Conclusion. Although SVF treatment appears to decrease the inflammatory cytokine levels in the nasal mucosa, a single SVF injection was not effective in terms of symptom improvement and patient satisfaction. Further trials are needed to identify a more practical and useful regenerative treatment modality for patients with ENS.
참고문헌 (30)
- Oluwole M, "An audit of the early complications of turbinectomy", Ann R Coll Surg Engl, 76(5), pp.339~341 (1994)
- Houser SM, "Surgical treatment for empty nose syndrome", Arch Otolaryngol Head Neck Surg, 133(9), pp.858~863 (2007)
- Houser SM, "Empty nose syndrome associated with middle turbinate resection", Otolaryngol Head Neck Surg, 135(6), pp.972~973 (2006)
- Kuan EC, "Empty nose syndrome", Curr Allergy Asthma Rep, 15(1), pp.493~ (2015)
- Shah K, "Empty nose syndrome and atrophic rhinitis", Ann Allergy Asthma Immunol, 117(3), pp.217~220 (2016)
- Jung JH, "Costal cartilage is a superior implant material than conchal cartilage in the treatment of empty nose syndrome", Otolaryngol Head Neck Surg, 149(3), pp.500~505 (2013)
- Modrzynski M., "Hyaluronic acid gel in the treatment of empty nose syndrome", Am J Rhinol Allergy, 25(2), pp.103~106 (2011)
- Saafan ME, "Acellular dermal (alloderm) grafts versus silastic sheets implants for management of empty nose syndrome", Eur Arch Otorhinolaryngol, 270(2), pp.527~533 (2013)
- Leong SC, "The clinical efficacy of surgical interventions for empty nose syndrome: a systematic review", Laryngoscope, 125(7), pp.1557~1562 (2015)
- Coste A, "Empty nose syndrome", Eur Ann Otorhinolaryngol Head Neck Dis, 129(2), pp.93~97 (2012)
- Dayal A, "Impact of middle versus inferior total turbinectomy on nasal aerodynamics", Otolaryngol Head Neck Surg, 155(3), pp.518~525 (2016)
- Kang SK, "Autologous adipose tissue-derived stromal cells for treatment of spinal cord injury", Stem Cells Dev, 15(4), pp.583~594 (2006)
- Kim DY, "Effects of platelet-rich plasma, adipose-derived stem cells, and stromal vascular fraction on the survival of human transplanted adipose tissue", J Korean Med Sci, 29(Suppl 3), pp.S193~S200 (2014)
- Lataillade JJ, "New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy", Regen Med, 2(5), pp.785~794 (2007)
- Premaratne GU, "Stromal vascular fraction transplantation as an alternative therapy for ischemic heart failure: anti-inflammatory role", J Cardiothorac Surg, 6, pp.43~ (2011)
- Rodriguez JP, "Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety", Int Arch Med, 5, pp.5~ (2012)
- Thamboo A, "Defining surgical criteria for empty nose syndrome: validation of the office-based cotton test and clinical interpretability of the validated Empty Nose Syndrome 6-Item Questionnaire", Laryngoscope, 127(8), pp.1746~1752 (2017)
- Jang YJ, "Empty nose syndrome: radiologic findings and treatment outcomes of endonasal microplasty using cartilage implants", Laryngoscope, 121(6), pp.1308~1312 (2011)
- Riechelmann H, "Biological markers in nasal secretions", Eur Respir J, 21(4), pp.600~605 (2003)
- Jiang C, "Assessment of surgical results in patients with empty nose syndrome using the 25-item Sino-Nasal Outcome Test Evaluation", JAMA Otolaryngol Head Neck Surg, 140(5), pp.453~458 (2014)
- Palumbo P, "In vitro evaluation of different methods of handling human liposuction aspirate and their effect on adipocytes and adipose derived stem cells", J Cell Physiol, 230(8), pp.1974~1981 (2015)
- Phipps KD, "Alternatively activated M2 macrophages improve autologous fat graft survival in a mouse model through induction of angiogenesis", Plast Reconstr Surg, 135(1), pp.140~149 (2015)
- Xu X, "The expansion of autologous adipose-derived stem cells in vitro for the functional reconstruction of nasal mucosal tissue", Cell Biosci, 5, pp.54~ (2015)
- Friji MT, "New regenerative approach to atrophic rhinitis using autologous lipoaspirate transfer and platelet-rich plasma in five patients: our experience", Clin Otolaryngol, 39(5), pp.289~292 (2014)
- Tan SS, "The utility of adipose-derived stem cells and stromal vascular fraction for oncologic soft tissue reconstruction: is it safe? A matter for debate", Surgeon, 15(4), pp.186~189 (2017)
- Scheithauer MO, "Surgery of the turbinates and “empty nose” syndrome", GMS Curr Top Otorhinolaryngol Head Neck Surg, 9 (2010)
- Tomassen P, "Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers", J Allergy Clin Immunol, 137(5), pp.1449~1459.e4 (2016)
- Luo Q, "Human neutrophil elastase induces MUC5AC overexpression in chronic rhinosinusitis through tumour necrosis factor-alpha converting enzyme", Acta Otolaryngol, 136(6), pp.641~648 (2016)
- Raphael GD, "Pathophysiology of rhinitis: lactoferrin and lysozyme in nasal secretions", J Clin Invest, 84(5), pp.1528~1535 (1989)
- Hauser-Kronberger C, "CGRP and substance P in intraepithelial neuronal structures of the human upper respiratory system", Regul Pept, 72(2-3), pp.79~85 (1997)